Rockwood’s $6.2 Billion Merger with Albemarle

The Firm is representing Rockwood Holdings, Inc. in connection with its merger with Albemarle Corporation.  In the merger, each share of Rockwood common stock will be exchanged for $50.65 in cash and 0.4803 of a share of Albemarle common stock, valuing the transaction at approximately $6.2 billion. Upon closing, Albemarle shareholders will own approximately 70% of the combined company and Rockwood shareholders will own approximately 30%. The transaction is subject to shareholder and regulatory approval and other customary closing conditions and is expected to close in the first quarter of 2015.

More >>

Stibbe advises Mylan

Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business.

More >>

Tags:  Stibbe

White & Case Advises on €580 Million Dual Tranche High Yield Offering by Fives

Global law firm White & Case LLP has advised joint bookrunners J.P. Morgan, Deutsche Bank, Barclays, BNP Paribas, HSBC and Société Générale on the refinancing of Fives existing senior and mezzanine debt through a high yield bond offering of an aggregate principal amount of €580 million.

The France-headquartered industrial engineering group’s offering is split into two tranches – €380 million 4.5 percent senior secured notes due 2021 and €200 million senior secured floating rate notes due 2020. As part of the transaction, Fives also entered into a new €90 million super senior revolving credit facility.
More >>

Tags:  White & Case LLP

Wragge Lawrence Graham & Co’s Life Sciences team advises on ProStrakan’s £230 million acquisition of Archimedes

 

Archimedes is a fast growing European speciality pharmaceutical company that provides advanced treatments within the therapeutic areas of pain, oncology and critical care. Its largest product is PecFent, a fentanyl nasal spray used in the management of cancer pain in patients who are already receiving maintenance opioid therapy for chronic cancer pain.
Archimedes also has a diversified portfolio of promoted and non-promoted pharmaceutical products. It has a strong European footprint with operations in the UK, France, Germany and Spain. It is based in Reading, UK with a development facility in Nottingham. 2013 revenue increased by 33 per cent to £41 million.

More >>

Tags:  Gowling WLG

Dechert Advises Pemberton on Strategic Relationship with Legal & General and the Launch of a New Direct Lending Platform

Dechert LLP advised Pemberton Asset Management Holdings Limited (“Pemberton”) on a strategic relationship with Legal & General. The deal sees the creation of a new Direct Lending platform for institutional investors, through which Pemberton will provide much-needed financing to mid-market companies in the UK and Europe. Legal and General has made a 40% equity investment in Pemberton and an initial commitment to invest €250 million in Direct Lending through the Pemberton platform, with further commitments intended in the future. The Pemberton platform is designed to appeal to major insurers and other institutions who wish to offer funding to mid-market companies. It allows those companies to access institutional funding at a time when bank financing is in decline. The transaction was led by Financial Services partner Gus Black.

More >>

Tags:  Dechert LLP

Eversheds advises Dŵr Cymru Welsh Water on £1.5 billion capital investment programme

Law firm Eversheds has advised Dŵr Cymru Welsh Water on its procurement of alliance agreements with partners appointed to deliver its £1.5 billion capital investment programme for 2015 to 2020.

The partners will work closely with Welsh Water throughout the investment period, known as Asset Management Plan 6 (AMP6), to deliver cost effective and sustainable outcomes that will benefit customers and the environment. As part of its AMP6 regulatory funding cycle Welsh Water will invest in improvements to its clean water and sewerage networks and treatment works.

More >>

Tags:  Eversheds Sutherland

Kirkland & Ellis Represents ABRY in $1.325B Sale of York Risk Services

Kirkland & Ellis LLP represented ABRY Partners, which announced today that it has entered into an agreement to sell its majority equity interest in York Risk Services Group to Onex Corporation for $1.325 Billion. ABRY has been invested in York, a premier provider of risk management, claims management and managed care services, since December 2010. The Kirkland team was led by corporate partners Joshua Kogan and Armand Della Monica, and debt finance partners Ashley Gregory and David Tarr.
More >>

Tags:  Kirkland & Ellis LLP

Hunton & Williams Represents Electricity Generating Public Company in USD453M Philippines Power Plant Partnership

Hunton & Williams (Thailand) Limited advised Thailand’s first independent power producer Electricity Generating Public Company Limited in its USD453 million (14,750 million Baht) acquisition of 40.95 percent indirect ownership interest in the 630 MW Masinloc power plant as part of a strategic partnership with global power company AES Corporation. The investment will provide EGCO with opportunities for expansion in the future as well as other long-term co-development prospects in SouthEast Asia.

More >>

Tags:  Hunton Andrews Kurth LLP

Shearman & Sterling Advises on Bank of Montreal’s $1.3 Billion Medium-Term Notes Offering

Shearman & Sterling represented BMO Capital Markets Corp., Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC and Wells Fargo Securities, LLC as lead underwriters in connection with a registered public offering of $1 billion aggregate principal amount of 1.300% Senior Notes due 2017 and $300 million aggregate principal amount of Floating Rate Notes due 2017 by Bank of Montreal, under its US medium-term note program.

More >>

Tags:  Shearman & Sterling LLP